| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6200846 | Ophthalmology | 2016 | 7 Pages |
Abstract
Routine IC moxifloxacin prophylaxis achieved a highly significant, 4-fold reduction in postoperative endophthalmitis in patients undergoing M-SICS. Compared with previous studies, having such a high volume of patients undergoing surgery during a relatively short 14-month time period strengthens the conclusion. This study provides further evidence that moxifloxacin is an effective IC prophylactic antibiotic and suggests that IC antibiotics should be considered for M-SICS and phacoemulsification.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Aravind MD, David F. MD, Sathvik Namburar, Anand MS, Ravilla D. MD,